Workup for Shortness of Breath in Pregnancy
Begin with a chest X-ray as the first imaging test, followed by a systematic evaluation for pulmonary embolism (the leading cause of pregnancy-related mortality), cardiac dysfunction, and other cardiopulmonary pathology based on clinical presentation and initial findings.
Initial Clinical Assessment
Focus your history and physical on distinguishing physiologic dyspnea of pregnancy from pathologic causes:
- Red flags requiring immediate workup: Chest pain, hemoptysis, syncope, severe tachycardia, hypoxia, unilateral leg swelling/pain, or acute onset dyspnea 1
- Cardiac symptoms: Palpitations, orthopnea, paroxysmal nocturnal dyspnea, or edema beyond typical pregnancy changes 1
- Risk factors for VTE: Personal or family history of thrombosis, thrombophilia, prolonged immobility, recent surgery 2
Diagnostic Algorithm
Step 1: Chest X-Ray First
Perform chest X-ray as the initial radiation-associated imaging test 3. This is safe in pregnancy (fetal radiation exposure <0.01 mGy, well below the 100 mGy threshold for fetal harm) and helps differentiate the diagnostic pathway 4.
Step 2: If PE is Suspected
The approach depends on leg symptoms and CXR findings:
With leg symptoms (unilateral swelling/pain):
- Perform bilateral compression ultrasound (CUS) of lower extremities first 3
- If positive → treat with anticoagulation
- If negative → proceed to pulmonary imaging based on CXR
Without leg symptoms:
- Skip leg ultrasound and proceed directly to pulmonary vascular imaging 3
CXR-based imaging pathway:
- Normal CXR → V/Q scan preferred over CTPA (strong recommendation) 3
- Lower maternal breast radiation exposure with V/Q scan
- If V/Q is nondiagnostic, proceed to CTPA 3
- Abnormal CXR → CTPA as next test 3
Step 3: Cardiac Evaluation
If PE workup is negative or clinical suspicion for cardiac dysfunction exists:
- Echocardiography with tissue Doppler imaging (TDI) to assess for:
Pregnant women with significant dyspnea may have subtle cardiac involvement including increased wall thickness, elevated PA pressures (mean 26.8 vs 19.0 mmHg in controls), and diastolic dysfunction even without overt heart disease 5.
Step 4: Other Cardiopulmonary Pathology
Based on CXR and clinical context, evaluate for:
- Pneumonia: Infiltrates on CXR, fever, productive cough
- Asthma exacerbation: Wheezing, history of asthma
- Pulmonary edema: Cardiogenic (echocardiography) or non-cardiogenic causes
- Pleural effusion: Visible on CXR 4
Critical Pitfalls to Avoid
Don't rely on D-dimer alone: D-dimer increases throughout normal pregnancy and has limited utility 6. Preliminary data suggest normal D-dimer with low clinical probability may exclude DVT, but this requires validation 6.
Don't delay imaging due to radiation concerns: PE causes 20% of maternal deaths in developed countries 3. All recommended imaging modalities (CXR, V/Q, CTPA) deliver fetal radiation doses well below harmful thresholds 4.
Don't dismiss cardiac causes: Pregnancy can unmask or induce myocardial dysfunction causing dyspnea even in previously healthy women 5. Echocardiography should be performed when PE is excluded but symptoms persist.
Don't use permissive hypercapnia: Unlike non-pregnant patients, maternal hypoxemia directly compromises fetal oxygenation. Maintain normal maternal oxygen saturation and avoid permissive hypercapnia strategies 7.
Quality of Evidence Considerations
The PE diagnostic algorithm is based on 2011 ATS/STR guidelines 3 with weak-to-strong recommendations on low-quality evidence, reflecting the ethical challenges of studying pregnant women. The 2023 multidisciplinary toolkit 2 and 2025 SMFM statement 1 provide more recent frameworks emphasizing systematic approaches to cardiovascular symptoms. The cardiac evaluation data 5 comes from a small observational study but represents the only systematic echocardiographic assessment of this population.